Latest filing published 30 Dec 2025 for Merus N.V., €245k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Genmab A/S is a declared insider of Merus N.V., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 16 December 2025 and the latest from 26 December 2025.
The open-market record is one-sided, with 4 purchases worth €29.0M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
A typical purchase (the median) is worth €5.6M. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 30 December 2025, the filings show an open-market purchase worth €245k in Merus N.V. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations